Halitta ya bayyana da farko a duniya da za su iya kawar da irin II ciwon sukari

Ko da yake an zaci cewa Type 2 ciwon sukari ne ya rinjayi mutum genes, masu bincike bayar da shawarar cewa ta ci gaba ne da karfi hade tare da matalauta abinci mai gina jiki da kuma kiba ga dogon lokaci na lokaci, musamman a cikin tsufa. A pancreas ne ko dai iya samar da isasshen insulin ko da Kwayoyin na jiki kawai ba ya amsa da shi, wadda take kaiwa zuwa dangerously high matakan da jini sugar.

A nasara da American masana kimiyya

Wannan yanayin da aka sani da suna insulin juriya, da kuma a halin yanzu babu wani likita hanya za mu bi da shi. Duk da haka, wani sabon magani ci gaba da wani rukuni na masana kimiyya daga Jami'ar California, zai iya zama ainihin nasara a wannan fagen.

A cewar New Scientist mujallar, da kullum kashi na magani, wanda aka bai wa beraye da insulin juriya, ya iya cece su daga wannan hali. Wannan shi ne na farko hali a duniya, a lokacin da wani magani iya yadda ya kamata "magani" ciwon sukari na biyu da irin.

Abin da ya haddasa insulin juriya

A binciken da tawagar zaci cewa alhakin tabbatar da cewa insulin juriya wani takamaiman enzyme da aka sani da LMPTP (low kwayoyin nauyi gina jiki tyrosine phosphatase). Yana za a iya samu a cikin hanta, da kuma, a fili, shi interacts da Kwayoyin dõmin su kasance resistant ga gaban insulin.

Amfani da wani sabon maganin da aka musamman tsara don hana ci gaban LMPTP, masana kimiyya zaci cewa shi zai ba da damar da insulin tsoka mai amsa sigina Kwayoyin "koyi" sake amsa insulin kullum. Don su ni'ima, suka sãmi abin da suka kasance dama.

"Our sakamakon nuna cewa LMPTP ne a key hanyar insulin juriya, da kuma cewa hanawa wannan musamman enzyme zai zama da amfani domin lura da ciwon sukari mellitus irin II", - ya ce tawagar a wani binciken da aka buga a mujallar "Nature."

Gwaji da wani sabon maganin a beraye

Domin wannan binciken, da miyagun ƙwayoyi da aka baki gudanar zuwa dama awon beraye. Da farko, an ciyar da tare da wani musamman babban mai, don haka suka ci gaba da kiba da ciwon sukari na biyu da irin.

A daidai wannan lokaci da beraye bai fuskanci wani gefen effects daga sabon maganin. Su Kwayoyin suna sake fara amsa ga gaban insulin da jini sugar matakan ragu zuwa al'ada a cikin wata daya.

A mataki na gaba shi ne don a duba ko da miyagun ƙwayoyi ne mai lafiya don amfani a mutum gwajinsu, kuma yanzu ga shi ne lokacin da ya dace.

A manyan dalilin mutuwar

Da ciwon sukari, musamman na biyu da irin za a ta bakwai jagorancin dalilin mutuwar dukan duniya ta 2030, a matsayin kudi na kiba ci gaba da tashi, yayin da yawan m diagnoses karin a breakneck taki.

Yawan mutanen da ke fama daga wannan yanayin, ya karu da 390 cikin dari a cikin past uku da rabi da suka gabata, kuma a halin yanzu akwai kawai hanyoyi don ya rage bayyanar cututtuka ko kashe da cutar, amma ba warke. Zai yiwu wani sabon maganin zai iya karshe canza wannan halin da ake ciki.